Cytarabine/High-dose Methotrexate/Rituximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cytarabine, high-dose methotrexate and rituximab that can be used in the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma, and mantle cell lymphoma.

**Synonyms:** - Cytarabine, Methotrexate, Rituximab - Cytarabine, Methotrexate, Rituximab-abbs - Cytarabine, Methotrexate, Rituximab-arrx - Cytarabine, Methotrexate, Rituximab-blit - Cytarabine, Methotrexate, Rituximab-pvvr - Cytarabine, Methotrexate, Rituximab-rite - Cytarabine, Methotrexate, Rituximab-rixa - Cytarabine, Methotrexate, Rituximab-rixi - R-HD-MTX/ARA-C - R-HD-MTX/ARA-C Regimen - Rituximab Plus HD MTX Plus HD AraC - Rituximab-HD-MTX/ARA-C - Rituximab-High-dose Methotrexate-High-dose Cytarabine - Rituximab/HD-Methotrexate/Cytarabine - Rituximab/High-dose MTX/ARA-C Regimen